Case Study: Takeda reduces time to rare disease diagnosis with Rabin Martin

Takeda shortens rare disease diagnosis journey by 5 years with Rabin Martin

Takeda sought to establish itself as a leader in rare diseases and address the serious challenge of prolonged diagnosis times for children. The vendor Rabin Martin supported this goal by designing Takeda's signature initiative, the Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease.

Rabin Martin served as the Secretariat for the Global Commission, creating its vision, identifying key barriers to diagnosis, recruiting global experts, and developing a report with actionable recommendations. The resulting Year-One Report was published on Rare Disease Day 2019 to widespread praise, was highlighted at major conferences, and was selected as a Lighthouse Project by the World Economic Forum. The work was successfully integrated into Takeda's early diagnosis strategy, and Rabin Martin is now working to relaunch the initiative for further impact.

Takeda